via Big Think
Every year, millions of patients are told that they have exhausted conventional treatment options.
With statistics showing the disturbing increase of cancer cases, it is unfortunately becoming common to have a loved one – relative or friend – suffering from the disease. There were an estimated 14.1 million cancer cases around the world in 2012. This number is expected to increase to 24 million by 2035 (WCRF). Having a loved one battling a disease such as cancer is a special kind of hell that only people who have experienced can really understand. It was exactly such people that created myTommorrows – a global platform, started in the Netherlands, that facilitates the contact between patients and innovative bio-tech companies.
Read more . . .
The Latest on: Innovative Treatments
via Google News
The Latest on: Innovative Treatments
- U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Canceron March 3, 2021 at 4:06 pm
The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA® ...
- Worms hold innovative key to wastewater treatmenton March 3, 2021 at 2:03 pm
Rapid urbanisation and a steadily rising population in cities and towns has left decades — old sanitation infrastructure in Zimbabwe under pressure.
- Purdue and Evidence In Motion expand partnership to offer new innovative health care certificationson March 3, 2021 at 8:06 am
Purdue University and Evidence In Motion (EIM) are expanding their partnership to offer two new specialty certifications for licensed health care providers in the U.S. – a certification in lifestyle ...
- Southern Custom Shutters Supplies and Installs Custom Window Treatmentson March 3, 2021 at 6:35 am
High Point, NC – Southern Custom Shutters has over three decades of industry experience. As a result, the company can offer its clients exceptional and affordable ...
- New Advanced Brain + Body Clinic Provides Hope for Treatment-Resistant Depression in Minneapolis Areaon March 3, 2021 at 5:52 am
Advanced Brain + Body Clinic (AB+BC) is a new interventional psychiatric clinic opening in Minnetonka, MN. Developed by psychiatrists Stephen Manlove, M.D. and Brian Johns, M.D., this new clinic will ...
- Azura Ophthalmics Announces Positive Topline Results From Phase 2 Program of the Company's Investigational Treatment for Meibomian Gland Dysfunctionon March 3, 2021 at 4:00 am
AZR-MD-001 meets primary endpoints of significant improvement in signs and symptoms of MGD and restoration of gland function Azura Ophthalmics Ltd., a clinical-stage ...
- Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemiaon March 2, 2021 at 9:30 pm
(NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that BRUKINSA ® (zanubrutinib) has been ...
- Innovative neurosurgical technique used in Tay-Sachs gene therapy clinical trialon March 2, 2021 at 9:10 pm
Oguz Cataltepe, MD, describes the innovative neurosurgical procedure used to treat patients in the new clinical trial for a gene therapy targeting infantile Tay-Sachs and Sandhoff diseases.
- Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA(TM) - New Innovative Treatment for Irritable Bowel Syndrome with Constipationon March 1, 2021 at 10:32 pm
MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD), ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today the Canadian commercial ...
- Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA™ - New Innovative Treatment for Irritable Bowel Syndrome with Constipationon March 1, 2021 at 4:17 pm
Knight Therapeutics Inc. (TSX: GUD), (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today the Canadian commercial availability of IBSRELA (tenapanor), a first-in-class ...
via Bing News
